These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12652400)

  • 1. A testament to sustained macrolide efficacy.
    Bishai W
    Clin Infect Dis; 2003 Apr; 36(7):935-6; author reply 936-7. PubMed ID: 12652400
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo veritas: in vitro macrolide resistance in systemic Streptococcus pneumoniae infections does result in clinical failure.
    Jacobs MR
    Clin Infect Dis; 2002 Sep; 35(5):565-9. PubMed ID: 12173130
    [No Abstract]   [Full Text] [Related]  

  • 3. A review of clinical failures associated with macrolide-resistant Streptococcus pneumoniae.
    Rzeszutek M; Wierzbowski A; Hoban DJ; Conly J; Bishai W; Zhanel GG
    Int J Antimicrob Agents; 2004 Aug; 24(2):95-104. PubMed ID: 15288306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptococcus pneumoniae: does antimicrobial resistance matter?
    Lynch JP; Zhanel GG
    Semin Respir Crit Care Med; 2009 Apr; 30(2):210-38. PubMed ID: 19296420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
    Feldman C
    J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of macrolide resistance during treatment of pneumococcal pneumonia.
    Musher DM; Dowell ME; Shortridge VD; Flamm RK; Jorgensen JH; Le Magueres P; Krause KL
    N Engl J Med; 2002 Feb; 346(8):630-1. PubMed ID: 11856810
    [No Abstract]   [Full Text] [Related]  

  • 7. Escalation of antimicrobial resistance among Streptococcus pneumoniae: implications for therapy.
    Lynch JP; Zhanel GG
    Semin Respir Crit Care Med; 2005 Dec; 26(6):575-616. PubMed ID: 16388429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New quinolones for the treatment of community-acquired pneumonia--contra].
    Egger M
    Dtsch Med Wochenschr; 2003 May; 128(19):1071. PubMed ID: 12736860
    [No Abstract]   [Full Text] [Related]  

  • 9. What is optimal antimicrobial therapy for bacteremic pneumococcal pneumonia?
    File TM; Mandell LA
    Clin Infect Dis; 2003 Feb; 36(4):396-8. PubMed ID: 12567295
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of moxifloxacin for treatment of penicillin-, macrolide- and multidrug-resistant Streptococcus pneumoniae in community-acquired pneumonia.
    Fogarty C; Torres A; Choudhri S; Haverstock D; Herrington J; Ambler J
    Int J Clin Pract; 2005 Nov; 59(11):1253-9. PubMed ID: 16236076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrolide and ketolide resistance with Streptococcus pneumoniae.
    Doern GV
    Med Clin North Am; 2006 Nov; 90(6):1109-24. PubMed ID: 17116439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteremic pneumococcal pneumonia associated with macrolide failure.
    Dylewski J; Davidson R
    Eur J Clin Microbiol Infect Dis; 2006 Jan; 25(1):39-42. PubMed ID: 16411124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of clarithromycin against Streptococcus pneumoniae expressing mef(A)-mediated resistance.
    Maglio D; Capitano B; Banevicius MA; Tessier PR; Nightingale CH; Nicolau DP
    Int J Antimicrob Agents; 2004 May; 23(5):498-501. PubMed ID: 15120730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fatal outcome of pneumococcal pneumonia--a consequence of macrolide resistance?].
    Sønderkaer KS; Harboe ZB; Høiby N; Skinhøj P
    Ugeskr Laeger; 2004 Apr; 166(18):1684-5. PubMed ID: 15174409
    [No Abstract]   [Full Text] [Related]  

  • 15. [Resistance to penicillin and erythromycin of Streptococcus pneumoniae and Streptococcus pyogenes isolated from community-acquired respiratory infections in Spain between 1986-1999 and its relationship with the use of beta-lactams and macrolides].
    Granizo Martínez JJ
    Rev Esp Quimioter; 2005 Mar; 18(1):83-5. PubMed ID: 15915241
    [No Abstract]   [Full Text] [Related]  

  • 16. Antimicrobial-resistant Streptococcus pneumoniae: trends and management.
    Jacobs MR
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):619-35. PubMed ID: 18847402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial resistance and treatment of community-acquired pneumonia.
    Mandell LA
    Clin Chest Med; 2005 Mar; 26(1):57-64. PubMed ID: 15802166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome of pneumococcal bacteremia, in vitro resistance, and antibiotic therapy.
    Torres-Tortosa M; Caballero-Granado J; Canueto J; Moreno-Maqueda I
    Clin Infect Dis; 2004 Mar; 38(5):763-4; author reply 765-6. PubMed ID: 14986265
    [No Abstract]   [Full Text] [Related]  

  • 19. Significance of macrolide resistance in Streptococcus pneumoniae.
    Nuermberger EL; Bishai WR
    J Antimicrob Chemother; 2003 Sep; 52(3):524-5; author reply 525. PubMed ID: 12888594
    [No Abstract]   [Full Text] [Related]  

  • 20. The clinical significance of macrolide-resistant Streptococcus pneumoniae: it's all relative.
    Nuermberger E; Bishai WR
    Clin Infect Dis; 2004 Jan; 38(1):99-103. PubMed ID: 14679455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.